- Home
- MIRA vs AQMS Comparison
MIRA vs AQMS Comparison
Compare MIRA & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRA
- AQMS
- Stock Information
- Founded
- MIRA 2020
- AQMS 2014
- Country
- MIRA United States
- AQMS United States
- Employees
- MIRA N/A
- AQMS N/A
- Industry
- MIRA Biotechnology: Pharmaceutical Preparations
- AQMS Metal Fabrications
- Sector
- MIRA Health Care
- AQMS Industrials
- Exchange
- MIRA Nasdaq
- AQMS Nasdaq
- Market Cap
- MIRA 26.5M
- AQMS 5.1M
- IPO Year
- MIRA 2023
- AQMS 2015
- Fundamental
- Price
- MIRA $1.38
- AQMS $3.62
- Analyst Decision
- MIRA Strong Buy
- AQMS Buy
- Analyst Count
- MIRA 1
- AQMS 1
- Target Price
- MIRA $17.00
- AQMS $30.00
- AVG Volume (30 Days)
- MIRA 248.1K
- AQMS 28.4K
- Earning Date
- MIRA 11-11-2025
- AQMS 11-13-2025
- Dividend Yield
- MIRA N/A
- AQMS N/A
- EPS Growth
- MIRA N/A
- AQMS N/A
- EPS
- MIRA N/A
- AQMS N/A
- Revenue
- MIRA N/A
- AQMS N/A
- Revenue This Year
- MIRA N/A
- AQMS N/A
- Revenue Next Year
- MIRA N/A
- AQMS $550.00
- P/E Ratio
- MIRA N/A
- AQMS N/A
- Revenue Growth
- MIRA N/A
- AQMS N/A
- 52 Week Low
- MIRA $0.73
- AQMS $3.37
- 52 Week High
- MIRA $2.56
- AQMS $46.00
- Technical
- Relative Strength Index (RSI)
- MIRA 45.42
- AQMS 42.43
- Support Level
- MIRA $1.35
- AQMS $3.59
- Resistance Level
- MIRA $1.72
- AQMS $4.35
- Average True Range (ATR)
- MIRA 0.08
- AQMS 0.29
- MACD
- MIRA 0.01
- AQMS 0.05
- Stochastic Oscillator
- MIRA 7.86
- AQMS 8.74
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.